Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn

NNWN / Seoul, 2017-06-11

Good news for health experts and orthopaedic surgeons. Researchers in South Korea have found out that degeneration of joint conditions such as osteoarthritis may be dealt with if old cells that get accumulated in our joints as we age, are removed. According to Researchers, it may significantly contribute in delaying the onset of age-related degenerative joint conditions, such as osteoarthritis.

The study may provide new insights into therapies targeting SnCs for the treatment of trauma and age-related degenerative joint disease, said Chaekyu Kim from the Ulsan National Institute of Science and Technology (UNIST) in South Korea. The study also presented a novel pharmacologic candidate that alleviates age-related osteoarthritis by selectively destroying SnCs.

What should be done? The study says:

The selective removal of Senescent cells (SnCs) from joints could reduce the development of post-traumatic osteoarthritis and allow new cartilage to grow and repair joints, according to the findings of the research published in the journal Nature Medicine. SnCs accumulate with age in many vertebrate tissues and are present at sites of age-related pathology.

Although SnC cells play an essential role in wound healing and injury repair, they often are not cleared from knee and cartilage tissue after an injury, thereby contributing to the development of osteoarthritis.They may also promote cancer incidence in tissues, the journal quoted researchers.

How study was conducted?

For the study, the team took both younger and older mice and cut their anterior cruciate ligaments (ACL) to minic injury. They, then, administered injections of an experimental drug, named UBX0101 to selectively remove SnCs after anterior cruciate ligament transection (ACLT) surgery.

The results showed that aged mice did not exhibit signs of cartilage regeneration after treatment with UBX0101 injections. According to the research team, the relevance of their findings to human disease was validated using chondrocytes isolated from arthritic patients